Banks - Regional
Compare Stocks
4 / 10Stock Comparison
CHYM vs OPFI vs SOFI vs DAVE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Financial - Credit Services
Software - Application
CHYM vs OPFI vs SOFI vs DAVE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Software - Application | Financial - Credit Services | Software - Application |
| Market Cap | $7.61B | $852M | $20.40B | $3.35B |
| Revenue (TTM) | $2.19B | $544M | $4.77B | $552M |
| Net Income (TTM) | $-969M | $66M | $481M | $225M |
| Gross Margin | 85.9% | 96.2% | 75.1% | 81.5% |
| Operating Margin | -47.6% | 34.2% | 11.0% | 4.9% |
| Forward P/E | 112.9x | 5.5x | 26.5x | 19.1x |
| Total Debt | $135M | $333M | $1.82B | $75M |
| Cash & Equiv. | $466M | $49M | $4.93B | $81M |
CHYM vs OPFI vs SOFI vs DAVE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Chime Financial, In… (CHYM) | 100 | 55.1 | -44.9% |
| OppFi Inc. (OPFI) | 100 | 70.7 | -29.3% |
| SoFi Technologies, … (SOFI) | 100 | 87.9 | -12.1% |
| Dave Inc. (DAVE) | 100 | 92.9 | -7.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHYM vs OPFI vs SOFI vs DAVE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHYM plays a supporting role in this comparison — it may shine differently against other peers.
OPFI is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 1.69, yield 24.8%
- Lower volatility, beta 1.69, current ratio 7.44x
- Beta 1.69, yield 24.8%, current ratio 7.44x
- Lower P/E (5.5x vs 19.1x)
SOFI is the clearest fit if your priority is long-term compounding.
- 52.7% 10Y total return vs OPFI's 4.2%
DAVE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 47.5%, EPS growth 222.9%, 3Y rev CAGR 35.7%
- 47.5% revenue growth vs OPFI's 13.5%
- 40.8% margin vs CHYM's -46.2%
- +131.2% vs CHYM's -48.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 47.5% revenue growth vs OPFI's 13.5% | |
| Value | Lower P/E (5.5x vs 19.1x) | |
| Quality / Margins | 40.8% margin vs CHYM's -46.2% | |
| Stability / Safety | Beta 1.69 vs DAVE's 2.69 | |
| Dividends | 24.8% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +131.2% vs CHYM's -48.8% | |
| Efficiency (ROA) | 49.6% ROA vs CHYM's -49.8%, ROIC 11.1% vs -60.2% |
CHYM vs OPFI vs SOFI vs DAVE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHYM vs OPFI vs SOFI vs DAVE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OPFI leads in 3 of 6 categories
DAVE leads 2 • CHYM leads 0 • SOFI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
OPFI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SOFI is the larger business by revenue, generating $4.8B annually — 8.8x OPFI's $544M. DAVE is the more profitable business, keeping 40.8% of every revenue dollar as net income compared to CHYM's -46.2%. On growth, DAVE holds the edge at +36.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $544M | $4.8B | $552M |
| EBITDAEarnings before interest/tax | -$976M | $190M | $760M | $33M |
| Net IncomeAfter-tax profit | -$969M | $66M | $481M | $225M |
| Free Cash FlowCash after capex | $144M | $399M | -$2.6B | $327M |
| Gross MarginGross profit ÷ Revenue | +85.9% | +96.2% | +75.1% | +81.5% |
| Operating MarginEBIT ÷ Revenue | -47.6% | +34.2% | +11.0% | +4.9% |
| Net MarginNet income ÷ Revenue | -46.2% | +12.1% | +10.1% | +40.8% |
| FCF MarginFCF ÷ Revenue | +1.5% | +73.2% | -83.5% | +59.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -37.8% | — | +36.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -35.0% | +2.2% | -56.7% | +104.1% |
Valuation Metrics
OPFI leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 10.0x trailing earnings, OPFI trades at a 76% valuation discount to SOFI's 41.0x P/E. On an enterprise value basis, OPFI's 5.7x EV/EBITDA is more attractive than DAVE's 69.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $7.6B | $852M | $20.4B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $1.1B | $17.3B | $3.3B |
| Trailing P/EPrice ÷ TTM EPS | -7.15x | 9.99x | 41.03x | 18.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 112.89x | 5.51x | 26.45x | 19.07x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 5.72x | 22.75x | 69.52x |
| Price / SalesMarket cap ÷ Revenue | 3.48x | 1.43x | 4.28x | 6.55x |
| Price / BookPrice ÷ Book value/share | 32.04x | 0.85x | 1.91x | 10.23x |
| Price / FCFMarket cap ÷ FCF | 231.45x | 2.23x | — | 11.57x |
Profitability & Efficiency
DAVE leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
DAVE delivers a 84.5% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-68 for CHYM. CHYM carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to OPFI's 1.08x. On the Piotroski fundamental quality scale (0–9), OPFI scores 6/9 vs SOFI's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -67.9% | +23.1% | +5.9% | +84.5% |
| ROA (TTM)Return on assets | -49.8% | +9.2% | +1.1% | +49.6% |
| ROICReturn on invested capital | -60.2% | +26.4% | +3.6% | +11.1% |
| ROCEReturn on capital employed | -78.1% | +30.9% | +1.2% | +12.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.10x | 1.08x | 0.17x | 0.21x |
| Net DebtTotal debt minus cash | -$332M | $283M | -$3.1B | -$5M |
| Cash & Equiv.Liquid assets | $466M | $49M | $4.9B | $81M |
| Total DebtShort + long-term debt | $135M | $333M | $1.8B | $75M |
| Interest CoverageEBIT ÷ Interest expense | — | 3.70x | 0.45x | 22.86x |
Total Returns (Dividends Reinvested)
DAVE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OPFI five years ago would be worth $10,128 today (with dividends reinvested), compared to $5,123 for CHYM. Over the past 12 months, DAVE leads with a +131.2% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors DAVE at 2.6% vs CHYM's -20.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -28.0% | -4.0% | -41.7% | +13.6% |
| 1-Year ReturnPast 12 months | -48.8% | -8.8% | +23.0% | +131.2% |
| 3-Year ReturnCumulative with dividends | -48.8% | +405.4% | +192.5% | +4740.2% |
| 5-Year ReturnCumulative with dividends | -48.8% | +1.3% | -3.1% | -20.2% |
| 10-Year ReturnCumulative with dividends | -48.8% | +4.2% | +52.7% | -20.5% |
| CAGR (3Y)Annualised 3-year return | -20.0% | +71.6% | +43.0% | +2.6% |
Risk & Volatility
Evenly matched — OPFI and DAVE each lead in 1 of 2 comparable metrics.
Risk & Volatility
OPFI is the less volatile stock with a 1.69 beta — it tends to amplify market swings less than DAVE's 2.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAVE currently trades 86.6% from its 52-week high vs CHYM's 42.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 1.69x | 2.54x | 2.69x |
| 52-Week HighHighest price in past year | $44.94 | $15.03 | $32.73 | $287.69 |
| 52-Week LowLowest price in past year | $16.17 | $7.36 | $12.56 | $105.83 |
| % of 52W HighCurrent price vs 52-week peak | +42.3% | +65.8% | +48.9% | +86.6% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 74.6 | 41.9 | 51.5 |
| Avg Volume (50D)Average daily shares traded | 4.7M | 487K | 65.8M | 607K |
Analyst Outlook
OPFI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CHYM as "Buy", OPFI as "Buy", SOFI as "Hold", DAVE as "Buy". Consensus price targets imply 39.4% upside for CHYM (target: $27) vs -26.7% for OPFI (target: $7). OPFI is the only dividend payer here at 24.76% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $26.50 | $7.25 | $20.89 | $309.25 |
| # AnalystsCovering analysts | 8 | 5 | 27 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +24.8% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 0 | — |
| Dividend / ShareAnnual DPS | — | $2.45 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +1.8% | +0.3% | +1.3% |
OPFI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). DAVE leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.
CHYM vs OPFI vs SOFI vs DAVE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHYM or OPFI or SOFI or DAVE a better buy right now?
For growth investors, Dave Inc.
(DAVE) is the stronger pick with 47. 5% revenue growth year-over-year, versus 13. 5% for OppFi Inc. (OPFI). OppFi Inc. (OPFI) offers the better valuation at 10. 0x trailing P/E (5. 5x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHYM or OPFI or SOFI or DAVE?
On trailing P/E, OppFi Inc.
(OPFI) is the cheapest at 10. 0x versus SoFi Technologies, Inc. at 41. 0x. On forward P/E, OppFi Inc. is actually cheaper at 5. 5x.
03Which is the better long-term investment — CHYM or OPFI or SOFI or DAVE?
Over the past 5 years, OppFi Inc.
(OPFI) delivered a total return of +1. 3%, compared to -48. 8% for Chime Financial, Inc. Class A Common Stock (CHYM). Over 10 years, the gap is even starker: SOFI returned +52. 7% versus CHYM's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHYM or OPFI or SOFI or DAVE?
By beta (market sensitivity over 5 years), OppFi Inc.
(OPFI) is the lower-risk stock at 1. 69β versus Dave Inc. 's 2. 69β — meaning DAVE is approximately 59% more volatile than OPFI relative to the S&P 500. On balance sheet safety, Chime Financial, Inc. Class A Common Stock (CHYM) carries a lower debt/equity ratio of 10% versus 108% for OppFi Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHYM or OPFI or SOFI or DAVE?
By revenue growth (latest reported year), Dave Inc.
(DAVE) is pulling ahead at 47. 5% versus 13. 5% for OppFi Inc. (OPFI). On earnings-per-share growth, the picture is similar: Dave Inc. grew EPS 222. 9% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Over a 3-year CAGR, DAVE leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHYM or OPFI or SOFI or DAVE?
Dave Inc.
(DAVE) is the more profitable company, earning 38. 3% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 38. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPFI leads at 32. 4% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — OPFI leads at 95. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHYM or OPFI or SOFI or DAVE more undervalued right now?
On forward earnings alone, OppFi Inc.
(OPFI) trades at 5. 5x forward P/E versus 112. 9x for Chime Financial, Inc. Class A Common Stock — 107. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHYM: 39. 4% to $26. 50.
08Which pays a better dividend — CHYM or OPFI or SOFI or DAVE?
In this comparison, OPFI (24.
8% yield) pays a dividend. CHYM, SOFI, DAVE do not pay a meaningful dividend and should not be held primarily for income.
09Is CHYM or OPFI or SOFI or DAVE better for a retirement portfolio?
For long-horizon retirement investors, OppFi Inc.
(OPFI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (24. 8% yield). Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OPFI: +4. 2%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHYM and OPFI and SOFI and DAVE?
These companies operate in different sectors (CHYM (Financial Services) and OPFI (Technology) and SOFI (Financial Services) and DAVE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CHYM is a small-cap high-growth stock; OPFI is a small-cap deep-value stock; SOFI is a mid-cap high-growth stock; DAVE is a small-cap high-growth stock. OPFI pays a dividend while CHYM, SOFI, DAVE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.